Expanded Hemodialysis Therapy Market Growth, Size, Trends, Revenue, Share and Future Outlook: SPER Market Research

Q: How can I get a sample report on the Expanded Hemodialysis Therapy Market?

You can get the sample pages by clicking the link - Click Here

Published: Nov 2023	Report ID: HLCA2365	Pages: 1 - 235	Formats^*:
Category : Healthcare

Expanded Hemodialysis Therapy Market Introduction and Overview

According to SPER Market Research, the Global Expanded Hemodialysis Therapy Market is estimated to reach USD XX billion by 2033 with a CAGR of 5.0%.

The report includes an in-depth analysis of the Global Expanded Hemodialysis Therapy market, including market size and trends, product mix, distribution channels, and supplier analysis. A life-sustaining treatment for patients with end-stage kidney disease is hemodialysis. It assists in the blood's removal of waste materials, extra fluid, and electrolytes, all of which help control and lessen kidney failure symptoms. Hemodialysis is not a cure for kidney disease, although it can greatly enhance many patients' quality of life. For a few, it acts as a stopgap measure before kidney transplantation, the permanent cure for kidney failure.

Market Opportunities and Challenges

Opportunities: The growing number of people worldwide who suffer from chronic renal illnesses. Due to the fact that kidney failure halts the process of cleansing blood and waste outflow, innovative medical devices must be used externally to filter the blood. Therefore, it is projected that throughout the forecast period, the growing prevalence of chronic renal disorders worldwide would present profitable potential prospects for market expansion. Furthermore, Diabetes and hypertension have increased significantly in recent years as a result of poor diet, sedentary lifestyle, limited physical exercise, increasing alcohol intake, and other factors. People who have such disorders are thought to be more likely to acquire a kidney ailment. Thus, renal failure due to lifestyle illnesses is expected to boost adoption of expanded hemodialysis therapy and, as a result, market size.

Challenges: The risks and complications that come with dialysis Patients receiving expanded hemodialysis treatments can have severe side effects while receiving treatment. Anemia, or the body's lack of red blood cells, is one of the most frequent side effects. Additionally, patients undergoing extended hemodialysis may have body-wide pain, warmth, redness, and swelling. Combined, these challenges will make it difficult for the industry to grow throughout the projected timeframe. The dialysis market is extremely competitive and diverse due to its large number of competitors. In the hemodialyser and peritoneal dialysis market, Tier I companies, mid-tier companies, and start-up companies all compete. Businesses are trying to get visibility in the market in this fiercely competitive field.

Get more information on this report: Download Free Sample PDF

Market Competitive Landscape

The market for Expanded Hemodialysis Therapy is highly consolidated. Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Cantel Medical Corp., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co, Ltd., Nipro Corporation, NxStage Medical Corp., Satellite Healthcare Inc., MEDIVATORS Inc. Some of the market key players in global Expanded Hemodialysis Therapy market.

Scope of the Report:

Report Metric	Details
Market size available for years	2019-2033
Base year considered	2022
Forecast period	2023-2033
Segments covered	By Product, By Modality, Application By End User
Regions covered	North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
Companies Covered	Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Cantel Medical Corp., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co, Ltd., Nipro Corporation, NxStage Medical Corp., Satellite Healthcare Inc., MEDIVATORS Inc.

COVID-19 Impact on Global Expanded Hemodialysis Therapy Market

The COVID-19 pandemic impacted nearly all industries and caused severe financial difficulty for healthcare services by rising healthcare costs. The adoption of social distancing norms and the change of standard operating procedures impeded the day-to-day functioning of numerous healthcare services, including dialysis processes. Many hospitals halted or rescheduled routine care and only offered emergency care. Despite the coronavirus epidemic, emergency dialysis procedures were performed in medical facilities. As the number of COVID-19 cases dropped in numerous countries, healthcare facilities resumed delivering healthcare services, eventually returning to pre-pandemic levels and positively improving the market landscape.

Key Target Audience

Nephrologists and Healthcare Providers
Dialysis Centers and Hospitals
Patients with Kidney Disease
Caregivers and Family Members
Medical Device Manufacturers
Pharmaceutical Companies
Healthcare Insurers and Payers
Regulatory Agencies
Researchers and Academics

Our in-depth analysis of the Expanded Hemodialysis Therapy Market includes the following segments:

By Product:	Machine Dialyzers Concentrates Dialysates Catheters
By Modality:	Short Daily Conventional Long term Nocturnal
By Application:	Priced Equipment Service Consumable Drug
By End Use:	Hospital Independent Dialysis Home Dialysis
By Region:	Asia-Pacific Europe Middle East & Africa North America Latin America

Key Topics Covered in the Report

Global Expanded Hemodialysis Therapy Market Size (FYâ€™2023-FYâ€™2033)
Overview of Global Expanded Hemodialysis Therapy Market
Segmentation of Global Expanded Hemodialysis Therapy Market By Product (Machine, Dialyzers, Concentrates, Dialysates, Catheters)
Segmentation of Global Expanded Hemodialysis Therapy Market By Modality (Short Daily, Conventional Long Term, Nocturnal)
Segmentation of Global Expanded Hemodialysis Therapy Market By Application (Priced Equipment, Service, Consumable, Drug)
Segmentation of Global Expanded Hemodialysis Therapy Market By End User (Hospital, Independent Dialysis, Home Dialysis)
Statistical Snap of Global Expanded Hemodialysis Therapy Market
Expansion Analysis of Global Expanded Hemodialysis Therapy Market
Problems and Obstacles in Global Expanded Hemodialysis Therapy Market
Competitive Landscape in the Global Expanded Hemodialysis Therapy Market
Impact of COVID-19 and Demonetization on Global Expanded Hemodialysis Therapy Market
Details on Current Investment in Global Expanded Hemodialysis Therapy Market
Competitive Analysis of Global Expanded Hemodialysis Therapy Market
Prominent Players in the Global Expanded Hemodialysis Therapy Market
SWOT Analysis of Global Expanded Hemodialysis Therapy Market
Global Expanded Hemodialysis Therapy Market Future Outlook and Projections (FYâ€™2023-FYâ€™2033)
Recommendations from Analyst

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source

2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERâ€™s internal database
2.1.4. Premium insight from KOLâ€™s

2.2. Market size estimation

2.2.1. Top-down and Bottom-up approach

2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis

4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges

4.2. COVID-19 Impacts of the Global Expanded Hemodialysis Therapy Market

5. Market variable and outlook

5.1. SWOT Analysis

5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats

5.2. PESTEL Analysis

5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape

5.3. PORTERâ€™s Five Forces

5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry

5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Expanded Hemodialysis Therapy Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Expanded Hemodialysis Therapy Market

7. Global Expanded Hemodialysis Therapy Market, By Product (USD Million)

7.1. Global Expanded Hemodialysis Therapy Market Value Share and Forecast, By Product, 2023-2033
7.2. Machine
7.3. Dialyzers
7.4. Concentrates
7.5. Dialysates
7.6. Catheters

8. Global Expanded Hemodialysis Therapy Market , By Modality (USD Million)

8.1. Global Expanded Hemodialysis Therapy Market Value Share and Forecast, By Modality, 2023-2033
8.2. Short Daily
8.3. Conventional Long term
8.4. Nocturnal

9. Global Expanded Hemodialysis Therapy Market , By Application (USD Million)

9.1. Global Expanded Hemodialysis Therapy Market Value Share and Forecast, By Application, 2023-2033
9.2. Priced Equipment
9.3. Service
9.4. Consumable
9.5. Drug

10. Global Expanded Hemodialysis Therapy Market , By End Use (USD Million)

10.1. Global Expanded Hemodialysis Therapy Market Value Share and Forecast, By End Use, 2023-2033
10.2. Hospital
10.3. Independent Dialysis
10.4. Home Dialysis

11. Global Expanded Hemodialysis Therapy Market Forecast, 2019-2033 (USD Million)

11.1. Global Expanded Hemodialysis Therapy Market Size and Market Share

12. Global Expanded Hemodialysis Therapy Market, By Product, 2019-2033 (USD Million)

12.1. Global Expanded Hemodialysis Therapy Market Size and Market Share By Product (2019-2026)
12.2. Global Expanded Hemodialysis Therapy Market Size and Market Share By Product (2027-2033)

13. Global Expanded Hemodialysis Therapy Market, By Modality, 2019-2033 (USD Million)

13.1. Global Expanded Hemodialysis Therapy Market Size and Market Share By Modality (2019-2026)
13.2. Global Expanded Hemodialysis Therapy Market Size and Market Share By Modality (2027-2033)

14. Global Expanded Hemodialysis Therapy Market, By Application, 2019-2033 (USD Million)

14.1. Global Expanded Hemodialysis Therapy Market Size and Market Share By Application (2019-2026)
14.2. Global Expanded Hemodialysis Therapy Market Size and Market Share By Application (2027-2033)

15. Global Expanded Hemodialysis Therapy Market, By End User, 2019-2033 (USD Million)

15.1. Global Expanded Hemodialysis Therapy Market Size and Market Share By End User (2019-2026)
15.2. Global Expanded Hemodialysis Therapy Market Size and Market Share By End User (2027-2033)

16. Global Expanded Hemodialysis Therapy Market, By Region, 2019-2033 (USD Million)

16.1. Global Expanded Hemodialysis Therapy Market Size and Market Share By Region (2019-2026)
16.2. Global Expanded Hemodialysis Therapy Market Size and Market Share By Region (2027-2033)
16.3. Asia-Pacific

16.3.1. Australia
16.3.2. China
16.3.3. India
16.3.4. Japan
16.3.5. South Korea
16.3.6. Rest of Asia-Pacific

16.4. Europe

16.4.1. France
16.4.2. Germany
16.4.3. Italy
16.4.4. Spain
16.4.5. United Kingdom
16.4.6. Rest of Europe

16.5. Middle East and Africa

16.5.1. Kingdom of Saudi Arabia
16.5.2. United Arab Emirates
16.5.3. Rest of Middle East & Africa

16.6. North America

16.6.1. Canada
16.6.2. Mexico
16.6.3. United States

16.7. Latin America

16.7.1. Argentina
16.7.2. Brazil
16.7.3. Rest of Latin America

17. Company Profile

17.1. Asahi Kasei Corporation

17.1.1. Company details
17.1.2. Financial outlook
17.1.3. Product summary
17.1.4. Recent developments

17.2. B. Braun Melsungen AG

17.2.1. Company details
17.2.2. Financial outlook
17.2.3. Product summary
17.2.4. Recent developments

17.3. Baxter International Inc.

17.3.1. Company details
17.3.2. Financial outlook
17.3.3. Product summary
17.3.4. Recent developments

17.4. Cantel Medical Corp.

17.4.1. Company details
17.4.2. Financial outlook
17.4.3. Product summary
17.4.4. Recent developments

17.5. Fresenius Medical Care AG & Co. KGaA

17.5.1. Company details
17.5.2. Financial outlook
17.5.3. Product summary
17.5.4. Recent developments

17.6. Nikkiso Co, Ltd.

17.6.1. Company details
17.6.2. Financial outlook
17.6.3. Product summary
17.6.4. Recent developments

17.7. Nipro Corporation

17.7.1. Company details
17.7.2. Financial outlook
17.7.3. Product summary
17.7.4. Recent developments

17.8. NxStage Medical Corp.

17.8.1. Company details
17.8.2. Financial outlook
17.8.3. Product summary
17.8.4. Recent developments

17.9. Satellite Healthcare Inc.

17.9.1. Company details
17.9.2. Financial outlook
17.9.3. Product summary
17.9.4. Recent developments

17.10. MEDIVATORS Inc.

17.10.1. Company details
17.10.2. Financial outlook
17.10.3. Product summary
17.10.4. Recent developments

17.11. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Frequently Asked Questions About This Report

How big is the Expanded Hemodialysis Therapy Market?

Expanded Hemodialysis Therapy Market is projected to reach USD XX billion by 2033, growing at a CAGR of 5.0% during the forecast period.

What is the growth rate of the Expanded Hemodialysis Therapy Market?

Expanded Hemodialysis Therapy Market grew in market size from 2022. The Market is expected to reach USD XX billion by 2033, at a CAGR of 5.0% during the forecast period.

What is the anticipated CAGR of the Expanded Hemodialysis Therapy Market?

Expanded Hemodialysis Therapy Market CAGR of 5.0% during the forecast period.

How can I get a sample report on the Expanded Hemodialysis Therapy Market?

You can get the sample pages by clicking the link - Click Here

What is the market size of the Expanded Hemodialysis Therapy Market?

Expanded Hemodialysis Therapy Market size is USD XX billion from 2023 to 2033.

Which segment is expected to Expanded Hemodialysis Therapy Market?

Expanded Hemodialysis Therapy Market Segment is covered By Product, By Modality, Application By End User.

Which region is expected to have the highest market share in the Expanded Hemodialysis Therapy Market?

The North America is anticipated to have the highest market share in the Expanded Hemodialysis Therapy Market.

Who are the key players in Expanded Hemodialysis Therapy Market?

The key players in the market include Companies Covered Covered Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Cantel Medical Corp., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co, Ltd., Nipro Corporation, NxStage Medical Corp., Satellite Healthcare Inc., MEDIVATORS Inc.

What is the conclusion of the Expanded Hemodialysis Therapy Market?

A life-sustaining treatment for patients with end-stage kidney disease is hemodialysis. It assists in the blood's removal of waste materials, extra fluid, and electrolytes, all of which help control and lessen kidney failure symptoms.